Abingworth
Abingworth
Abingworth works with entrepreneurs to turn breakthrough science into breakthrough medicine.
- Use:
- Date closing: -
- Amount: -
- Industry focus: Health;
- Total budget: 582M €
- Entity type: Private Equity Firm
- Vertical focus: All
- Website: https://www.abingworth.com/
- Status: Open
- Funding type: Equity investment;
- Geographic focus:
- Public/Private: Private
- Stage focus: Seed;
- Applicant target: Startup;
Overview
Since their first biotech investment over thirty years ago, Abingworth has helped young biopharma companies on both sides of the Atlantic turn the latest scientific discoveries into dozens of new treatments for patients.
Abingworth has raised 14 funds dedicated to investing in life sciences and healthcare.
Their two most recent, Abingworth Bioventures 8 and Abingworth Clinical Co-Development Fund 2, raised $466 million and $583 million respectively and are actively investing.
The funds invest in private and public companies across three broad strategic areas: seed and early stage, development stage (including VIPEs and public markets) and clinical co-development.
Abingworth FAQ
Abingworth Reviews
Recommend to a Friend
Experience
No data experience
Getting the funds
No data getting funds
Simple process
Abingworth News
Featured Funds
- Usage: R&D;
- Entity type: Public Agency
- Total: 1B €
- Funding type: Grant;
- Status: Open
- Geographic focus: EU; Eureka associated countries;
- 1 reviews 25 questions
- Usage: R&D; Go2Market; Other; Scale-up;
- Entity type: Accelerator
- Funding type: In kind; Other;
- Status: Open
- Geographic focus: EU; Europe;
- 0 reviews 0 questions
- Usage: R&D; Go2Market;
- Entity type: Public Agency
- Funding type: Grant;
- Geographic focus: Sweden;
- 0 reviews 0 questions